Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Broaddus

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Oncotarget|November 16, 2017
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trialsHelen J MacKay, Douglas A Levine, Victoria L Bae-Jump, et al.
JCI Insight|January 19, 2017
Metastasis regulation by PPARD expression in cancer cellsXiangsheng Zuo, Weiguo Xu, Min Xu, et al.
JCO Precision Oncology|October 16, 2018
Clinical Use of Precision Oncology Decision SupportAmber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Journal of Cancer Research and Clinical Oncology|July 17, 2019
Genetic profiling as a clinical tool in advanced parathyroid carcinomaMerve Kutahyalioglu, Ha T Nguyen, Lily Kwatampora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
JCO Precision Oncology|October 31, 2017
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine StudyApostolia-Maria Tsimberidou, David S Hong, Yang Ye, et al.
Cancer Cell|February 16, 2013
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancerDa Yang, Yan Sun, Limei Hu, et al.
Plos One|January 4, 2013
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganizationJ Saadi Imam, Jason R Plyler, Hima Bansal, et al.
JCO Precision Oncology|September 14, 2020
Targeting <i>ERBB2</i> (<i>HER2</i>) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional IndicationsEcaterina E Ileana Dumbrava, Kavitha Balaji, Kanwal Raghav, et al.
Oncotarget|January 27, 2017
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarrayHui Chen, Rajesh R Singh, Xinyan Lu, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Oncotarget|November 16, 2017
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trialsHelen J MacKay, Douglas A Levine, Victoria L Bae-Jump, et al.
JCI Insight|January 19, 2017
Metastasis regulation by PPARD expression in cancer cellsXiangsheng Zuo, Weiguo Xu, Min Xu, et al.
JCO Precision Oncology|October 16, 2018
Clinical Use of Precision Oncology Decision SupportAmber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Journal of Cancer Research and Clinical Oncology|July 17, 2019
Genetic profiling as a clinical tool in advanced parathyroid carcinomaMerve Kutahyalioglu, Ha T Nguyen, Lily Kwatampora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
JCO Precision Oncology|October 31, 2017
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine StudyApostolia-Maria Tsimberidou, David S Hong, Yang Ye, et al.
Cancer Cell|February 16, 2013
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancerDa Yang, Yan Sun, Limei Hu, et al.
Plos One|January 4, 2013
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganizationJ Saadi Imam, Jason R Plyler, Hima Bansal, et al.
JCO Precision Oncology|September 14, 2020
Targeting <i>ERBB2</i> (<i>HER2</i>) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional IndicationsEcaterina E Ileana Dumbrava, Kavitha Balaji, Kanwal Raghav, et al.
Oncotarget|January 27, 2017
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarrayHui Chen, Rajesh R Singh, Xinyan Lu, et al.
Pageof 10